Loading...
Human farnesyl pyrophosphate synthase is allosterically inhibited by its own product
Farnesyl pyrophosphate synthase (FPPS) is an enzyme of the mevalonate pathway and a well-established therapeutic target. Recent research has focused around a newly identified druggable pocket near the enzyme's active site. Pharmacological exploitation of this pocket is deemed promising; however...
Saved in:
| Published in: | Nat Commun |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Nature Publishing Group
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5253651/ https://ncbi.nlm.nih.gov/pubmed/28098152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms14132 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|